4.7 Article

Phycocyanin stimulates ulcerative colitis healing via selective activation of cannabinoid receptor-2, intestinal mucosal healing, Treg accumulation, and p38MAPK/MK2 signaling inhibition

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide

Alaa M. Ali et al.

Summary: This study suggests that activation of CB2 receptors by AM1241 can effectively slow down or reverse the progression of liver fibrosis through various mechanisms including inflammation inhibition, increased antioxidant capacity, and promotion of liver cell regeneration.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Review Biology

Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies

Steffen Braune et al.

Summary: The application of cytostatic drugs or natural substances to inhibit cancer growth and progression is an important subject in cancer research. Interest in marine bioresources, particularly algae and cyanobacteria, and their bioactive ingredients, has grown significantly. Arthrospira's phycocyanin has been identified as a potential active ingredient with therapeutic properties including anti-oxidant, anti-inflammatory, immune-modulatory, and anti-cancer activities.

LIFE-BASEL (2021)

Article Pharmacology & Pharmacy

Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response

Barbara Betonico Berg et al.

Summary: Cannabidiol (CBD) treatment in mice with acute graft-versus-host disease (aGVHD) successfully reduced inflammation levels and increased survival rates by enhancing intestinal cannabinoid receptor type 2 (CB2) receptor expression, demonstrating its potential therapeutic applications in patients undergoing bone marrow transplantation.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)

Article Pharmacology & Pharmacy

Cannabis and the Gastrointestinal Tract

Lawrence Cohen et al.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2020)

Review Gastroenterology & Hepatology

Insights into the role of cannabis in the management of inflammatory bowel disease

Sherman Picardo et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

P398 Cannabis induces clinical and endoscopic improvement in moderately active ulcerative colitis (UC)

T Naftali et al.

Journal of Crohns & Colitis (2018)

Review Immunology

Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease

Holm H. Uhlig et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)

Review Immunology

Toll-like Receptors and inflammatory Bowel Disease

Yue Lu et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Pharmacology & Pharmacy

Astaxanthin-Rich Haematococcus pluvialis Algal Hepatic Modulation in D-Galactose-Induced Aging in Rats: Role of Nrf2

Farouk Kamel El-Baz et al.

ADVANCED PHARMACEUTICAL BULLETIN (2018)

Article Biochemistry & Molecular Biology

The role of CB1 in intestinal permeability and inflammation

Mustafa A. Karwad et al.

FASEB JOURNAL (2017)

Review Chemistry, Multidisciplinary

Brain cannabinoid receptor 2: expression, function and modulation

De-Jie Chen et al.

ACTA PHARMACOLOGICA SINICA (2017)

Article Gastroenterology & Hepatology

Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK

Ya-Jing Feng et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Multidisciplinary Sciences

Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota

Chih-Jung Chang et al.

NATURE COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

SwissTargetPrediction: a web server for target prediction of bioactive small molecules

David Gfeller et al.

NUCLEIC ACIDS RESEARCH (2014)

Article Neurosciences

Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction

Rebecca Hartzell Robinson et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)

Article Medicine, Research & Experimental

Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis

Yu Y. Li et al.

LABORATORY INVESTIGATION (2013)

Review Pharmacology & Pharmacy

Cannabinoids and the gut: New developments and emerging concepts

Angelo A. Izzo et al.

PHARMACOLOGY & THERAPEUTICS (2010)

Article Gastroenterology & Hepatology

Activation of the Cannabinoid 2 Receptor (CB2) Protects Against Experimental Colitis

Martin A. Storr et al.

INFLAMMATORY BOWEL DISEASES (2009)

Article Gastroenterology & Hepatology

Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-induced Colitis

Philip Alex et al.

INFLAMMATORY BOWEL DISEASES (2009)

Review Immunology

Intestinal mucosal barrier function in health and disease

Jerrold R. Turner

NATURE REVIEWS IMMUNOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation

Driss El Kebir et al.

CIRCULATION RESEARCH (2008)